🔗 Permalink

Inventor profile of:

Lawrence Charnas

City:

Natick, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-12-11

Top Assignees for applications by Lawrence Charnas

The entities that hold a legal rights for patent applications filed by inventor Charnas Lawrence:

SHIRE HUMAN GENETIC THERAPIES, INC. 7 Lexington, MA United States
SHIRE HUMAN GENETIC THERAPIES, INC. 2 Cambridge, MA United States
Takeda Pharmaceutical Company Limited 2 Osaka, Japan
Regents of the University of Minnesota 1 Minneapolis, MN United States
SYNAGEVA BIOPHARMA CORP. 1 LEXINGTON, MA United States

Recent patent applications by Charnas Lawrence

Lawrence Charnas from Natick, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-11

US20250375506A1

Human necessities

CNS DELIVERY OF THERAPEUTIC AGENTS

#2 | 2025-05-22

US20250161417A1

Human necessities

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A

#3 | 2023-06-01

US20230165942A1

Human necessities

CNS DELIVERY OF THERAPEUTIC AGENTS

#4 | 2021-06-03

US20210163603A1

Chemistry; metallurgy

ANTI-FLT-1 ANTIBODIES IN TREATING DUCHENNE MUSCULAR DYSTROPHY

#5 | 2020-12-31

US20200405825A1

Human necessities

Methods and compositions for CNS delivery of arylsulfatase A

#6 | 2020-07-30

US20200237883A1

Human necessities

STABLE FORMULATIONS FOR CNS DELIVERY OF ARYLSULFATASE A

#7 | 2020-04-16

US20200113981A1

Human necessities

CNS delivery of therapeutic agents

#8 | 2019-05-02

US20190125841A1

Human necessities

Stable formulations for CNS delivery of arylsulfatase A

#9 | 2018-11-01

US20180312593A1

Chemistry; metallurgy

Anti-FLT-1 Antibodies in Treating Duchenne Muscular Dystrophy

#10 | 2018-03-15

US20180071212A1

Human necessities

Methods and compositions for CNS delivery of arylsulfatase A

#11 | 2017-02-16

US20170042978A1

Human necessities

CNS delivery of therapeutic agents

#12 | 2015-12-17

US20150361174A1

Chemistry; metallurgy

Anti-FLT-1 antibodies in treating duchenne muscular dystrophy

#13 | 2014-12-25

US20140377244A1

Human necessities

STABLE FORMULATIONS FOR CNS DELIVERY OF ARYLSULFATASE A

#14 | 2014-02-13

US20140044697A1

Human necessities

Methods for treating lysosomal acid lipase deficiency

#15 | 2013-12-12

US20130330317A1

Human necessities

Methods for Treating Lysosomal Acid Lipase Deficiency

#16 | 2012-01-12

US20120009171A1

Human necessities

Methods and compositions for CNS delivery of arylsulfatase A

#17 | 2012-01-05

US20120003202A1

Human necessities

CNS delivery of therapeutic agents

InventorID:

566915 ⎘